According to recent study by Nova one advisor, the U.S. circulating tumor cells market size was estimated at USD 4.85 billion in 2023 and is projected to hit around USD 16.15 billion by 2033, growing at a CAGR of 12.78% during the forecast period from 2024 to 2033.
According to recent study by Nova one advisor, the U.S. circulating tumor cells market size was estimated at USD 4.85 billion in 2023 and is projected to hit around USD 16.15 billion by 2033, growing at a CAGR of 12.78% during the forecast period from 2024 to 2033.